Comparison of Antiplatelet Effects of Sotagliflozin to FDA-approved Antiplatelet Drugs

NCT06933056 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Platelet Function and Reactivity Tests

Interventions

DRUG: Sotagliflozin (SOTA) followed by 3 drugs in a random order
DRUG: Aspirin followed by 3 drugs in a random order
DRUG: Clopidogrel followed by 3 drugs in a random order
DRUG: Eliquis followed by 3 drugs in a random order

Sponsor

University of Michigan

Collaborators

[object Object]